Trial intelligence / Profile preview

Padagis' Roflumilast Cream 0.3% vs Zoryve in Plaque Psoriasis

NCT05763082Phase 3Completed

Sponsor
Padagis
Start
Feb 2023
Primary completion
Aug 2023
Countries
1
01

Overview

A Phase 3 trial of roflumilast vehicle cream in plaque psoriasis, sponsored by Padagis. Started Feb 2023; status: completed.

02

Drugs

roflumilast vehicle cream
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT05763082.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05763082.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call